News - Appointments

David Atkins becomes CEO at Congenica

David Atkins

David Atkins, a diagnostics and healthcare executive, has been appointed chief executive officer of Congenica Ltd to lead the global expansion of its clinical genomics business.

Country: United Kingdom

Read more

Robert Friesen named CSO at Ablynx

Robert Friesen

Ablynx NV has named Robert Friesen, an experienced R&D executive, to be its chief scientific officer from 1 March.

Country: Belgium

Read more

Dominique Carouge to head business transformation at Sanofi

Dominique Carouge

Sanofi SA has appointed Dominique Carouge, its head of finance operations, to the position of head of business transformation for the company. Previously he managed global R&D.

Country: France

Read more

Ivan Møller joins Zealand Pharma management team

Ivan Møller

Zealand Pharma A/S has expanded its management team with the appointment, effective 1 March, of Ivan Møller to the newly created position of head of technical development and operations.

Country: Denmark

Read more

Martin Koch becomes COO at Inotrem

Martin Koch

France-based Inotrem SA has appointed Martin Koch as chief operating officer to help the company execute its business plan for anti-inflammatory compounds led by a product for septic shock.

Country: France

Read more

Frits van Alphen becomes CMO at Inositec

Frits van Alphen

Frits van Alphen, a pharma veteran, has joined Inositec AG as chief medical officer to oversee development of the company’s small molecule drugs to treat calcification disorders.

Country: Switzerland

Read more

Alligator Bioscience appoints head of business development

Anu Balendran

Sweden-based Alligator Bioscience AB has recruited Anu Balendran to head business development from 1 May.

Country: Sweden

Read more

Orchard appoints Frank Thomas as CFO

Frank Thomas

The UK gene therapy company Orchard Therapeutics Ltd has recruited Frank Thomas to the newly created position of chief financial officer and chief business officer to help oversee its global expans

Country: United Kingdom

Read more

Thomas Ulmer appointed CFO at Immatics

Thomas Ulmer

Thomas Ulmer is to join Immatics Biotechnologies GmbH as chief financial officer on 1 April as the company builds its T cell receptor and target discovery platforms.

Country: Germany

Read more

Glythera appoints CSO and strengthens advisory board

Robert Lutz

Glythera Ltd has appointed Robert Lutz as chief scientific officer to help it develop its portfolio of antibody-drug conjugates (ADCs) for difficult-to-treat cancers.

Country: United Kingdom

Read more